NantKwest

89 articles about NantKwest

• NantKwest Announces Presentation Of Preclinical Data Of HER2.taNK At The San Antonio Breast Cancer Symposium (SABCS)

  12/9/2015

• NantKwest Announces Presentation At The American Society of Hematology Annual Meeting; NK-92 Phase 1 Clinical Data On Dosing And Long-Term Survival In Relapsed Hematological Malignancies

  12/3/2015

• NantKwest Names Angela Wilson Chief Financial Officer

  11/17/2015

• NantKwest Announces Presentations At Upcoming Investment Conference Meetings

  11/3/2015

• NantKwest Augments, Strengthens Senior Management Team

  9/22/2015

• NantKwest Announces Prostate Cancer Foundation $1 Million Challenge Award To Study A Novel Natural Killer Cell Therapy In Prostate Cancer

  8/26/2015

• World's Richest Doctor Reaps $1.1 Billion Biotech Gain in Just Eight Months With NantKwest

  8/7/2015

• NantKwest Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares

  8/3/2015

• Patrick Soon-Shiong's NantKwest Sets Terms for $151 Million IPO

  7/17/2015